← FDA Drug Approvals (Drugs@FDA)

OXCARBAZEPINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MSN · Approved 2026-05-29

Drug application

FDA Application #

ANDA209020

Application type

Abbreviated New Drug Application (Generic)

Brand name

OXCARBAZEPINE

Generic name

OXCARBAZEPINE

Active ingredients

OXCARBAZEPINE

Dosage form

SUSPENSION

Route

ORAL

Marketing status

Prescription

Sponsor

MSN

Manufacturer

Novadoz Pharmaceuticals LLC

First approval

2026-05-29

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown